Rating History for Axsome Therapeutics (AXSM) by Morgan Stanley

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/24/2026 Sean Laaman Maintain Equalweight
(N/A)
207.00
(204.00)
 
 
  Details